Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Weishi Gutong Tie is a topical Traditional Chinese Medicine (TCM) plaster developed by Tianshui Wei's Pharmaceutical Co., Ltd. It is specifically indicated for the treatment of acute soft tissue injuries, as well as chronic musculoskeletal conditions such as osteoarthritis, cervical spondylosis, and lumbar muscle strain. The formulation consists of a complex mixture of herbal ingredients designed to promote local blood circulation, resolve blood stasis, and provide analgesic and anti-inflammatory effects. By applying the patch directly to the affected area, active herbal constituents are absorbed transdermally to reduce swelling and alleviate pain associated with tissue trauma or degenerative joint disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Weishi Gutong Tie.